In vivo actions of the selective 5-HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release

被引：0

作者：

Josep M. Casanovas

Olivier Berton

Pau Celada

Francesc Artigas

机构：

[1] Department of Neurochemistry,

[2] Institut d'Investigacions Biomèdiques de Barcelona (CSIC),undefined

[3] IDIBAPS,undefined

[4] 6th floor,undefined

[5] Rosselló,undefined

[6] 161,undefined

[7] E-08036 Barcelona,undefined

[8] Spain,undefined

[9] Present address: UCB Pharma,undefined

[10] Preclinical CNS Research Group,undefined

[11] Braine-l'Alleud,undefined

[12] Belgium,undefined

来源：

Naunyn-Schmiedeberg's Archives of Pharmacology | 2000年 / 362卷

关键词：

5-HT1A receptors Dorsal raphe nucleus Hippocampus Median raphe nucleus Microdialysis Prefrontal cortex Single unit recordings;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

We investigated the effects of the novel 5-HT1A receptor agonist BAY x 3702 on the serotonergic function in rat brain using single unit recordings in the dorsal raphe nucleus (DR) of anesthetized rats and in vivo microdialysis in freely moving rats. The administration of BAY x 3702 (0.25–4 µg/kg i.v.) suppressed the firing activity of 5-HT neurones. This effect was antagonized by a low dose of the selective 5-HT1A receptor antagonist WAY 100635 (5 µg/kg i.v.).

引用

页码：248 / 254

页数：6

共 50 条

[41] THE DESIGN OF SELECTIVE 5-HT1A RECEPTOR ANTAGONISTS
CLIFFE, IA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 30 - MEDI
[42] A selective 5-HT1a receptor agonist improves respiration in a mouse model of Rett syndrome
Levitt, Erica S.
Hunnicutt, Barbara J.
Knopp, Sharon J.
Williams, John T.
Bissonnette, John M.
JOURNAL OF APPLIED PHYSIOLOGY, 2013, 115 (11) : 1626 - 1633
[43] Drug evaluation:: PRX-00023, a selective 5-HT1A receptor agonist for depression
de Paulis, Tomas
CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (01) : 78 - 86
[44] Synthesis of Dihydrofuroaporphine Derivatives: Identification of a Potent and Selective Serotonin 5-HT1A Receptor Agonist
Liu, Zhili
Zhang, Hai
Ye, Na
Zhang, Jing
Wu, QianQian
Sun, Peihua
Li, Linyong
Zhen, Xuechu
Zhang, Ao
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (03) : 1319 - 1328
[45] Contrasting effects of chronic paroxetine on 5-HT1A control of dorsal raphe cell firing and 5-HT release
Davidson, C
Stamford, JA
NEUROREPORT, 1998, 9 (11) : 2535 - 2538
[46] Effects of chronic paroxetine on 5-HT1A autoreceptors controlling dorsal raphe cell firing and 5-HT release
Davidson, C
Stamford, JA
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 : P70 - P70
[47] In Vivo and Ex Vivo Characterization of Vilazodone as a Serotonin Reuptake Inhibitor and 5-HT1A Receptor Partial Agonist
Kehne, John H.
Bartoszyk, Gerd D.
Greiner, Hartmut E.
Pierz, Kerri A.
Renda, Matthew J.
Reed, Carol R.
Athanasiou, Maria C.
BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 238S - 238S
[48] EFFECTS OF NOVEL 5-HT1A RECEPTOR ANTAGONISTS ON MEASURES OF POSTSYNAPTIC 5-HT1A RECEPTOR ACTIVATION IN-VIVO
THIELEN, RJ
FRAZER, A
LIFE SCIENCES, 1995, 56 (07) : PL163 - PL168
[49] Oral post-lesion administration of 5-HT1A receptor agonist repinotan hydrochloride (Bay X 3702) attenuates NMDA-induced delayed neuronal death in rat magnocellular nucleus basalis
Harkany, T
Mulder, J
Horvath, KM
Keijser, J
Van der Meeberg, EK
Nyakas, C
Luiten, PGM
NEUROSCIENCE, 2001, 108 (04) : 629 - 642
[50] The activity of the serotonergic 5-HT1A receptor is modulated by voltage and sodium levels
Tauber, Merav
Ben Chaim, Yair
JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (06)

← 1 2 3 4 5 →